Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Do not mistake a submission for a prescription
Other drugmakers and digital health companies like Ro are scrambling to capitalize on the booming GLP-1 market, which analysts say could be worth more than $100 billion by the end of the decade
March 5, 2026: Novo Nordisk Receives FDA Warning Letter About Reporting Practices for GLP-1 Drugs Wegovys maker, Novo Nordisk, has received a warning letter from the FDA regarding its semaglutide and liraglutide GLP-1 drugs
These drugs have been well studied
US$ 29.07
US$ 24.35
US$ 22.47
US$ 20.79
US$ 27.19
